Clinical Correlates of Benefit From Radium‐223 Therapy in Metastatic Castration Resistant Prostate Cancer

Overview of attention for article published in The Prostate, December 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 42 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 4,803 followers.

RT @jualanmar: Radium-223 therapy is well tolerated with most patients reporting declines in pain scores and BSI in mCRPC https://t.co/BM8y…

Radium-223 therapy is well tolerated with most patients reporting declines in pain scores and BSI in mCRPC https://t.co/BM8yUi7AZh

RT @sogug1: Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer https://t.co/VpamJ7tf…

Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer https://t.co/4xmST4OEDQ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.